Skip to content
Merged
Show file tree
Hide file tree
Changes from all commits
Commits
Show all changes
23 commits
Select commit Hold shift + click to select a range
cb7e7c2
UPDATE: adding vomeronasal entry and sequence
pszgaspar Feb 9, 2026
a2111e2
UPDATE: adding VN1R1-5 annotation
pszgaspar Feb 11, 2026
4feb206
Merge branch 'master' of https://github.com/protwis/gpcrdb_data
pszgaspar Mar 13, 2026
9d9a71a
Merge branch 'master' of https://github.com/protwis/gpcrdb_data
pszgaspar Jun 24, 2026
7c04774
UPDATE: new G protein beta and gamma sequences
pszgaspar Aug 19, 2026
392607a
UPDATE: new structures that were converted from cif to pdb
pszgaspar Aug 19, 2026
a20418e
UPDATE: 9LL7 added to g protein chimera files
pszgaspar Aug 19, 2026
a4458fc
FIX: various fixes in evolvus annotation file
pszgaspar Aug 19, 2026
834c70d
UPDATE: base ligand reload files
pszgaspar Aug 19, 2026
df12706
UPDATE: gp143_human 6x50 and other segends update
pszgaspar Aug 19, 2026
2da506b
UPDATE: AI-based structure annotation data
pszgaspar Aug 19, 2026
a628b2b
Merge branch 'master' of https://github.com/protwis/gpcrdb_data
pszgaspar Aug 19, 2026
2d41f94
UPDATE: renaming uniprot entry names based on uniprot update
pszgaspar Aug 23, 2026
96fe706
UPDATE: Assay classification csv
pszgaspar Aug 23, 2026
1752064
FEATURE: new auxiliary small molecules tsv for structures
pszgaspar Aug 25, 2026
553c45e
UPDATE: removed deprecated files
pszgaspar Aug 25, 2026
7e146dd
UPDATE: wt annotation for new structure receptors
pszgaspar Aug 25, 2026
5842672
FIX: structure name fixes, redoing annotation of 8WGB
pszgaspar Aug 25, 2026
8703122
FIX: various annotation fixes
pszgaspar Aug 26, 2026
cb9f135
FIX: various annotation fixes
pszgaspar Aug 28, 2026
a60157d
FEATURE: tracking custom mappings for add_annotation
pszgaspar Aug 28, 2026
a141c20
UPDATE: new structures
pszgaspar Aug 28, 2026
09f400a
UPDATE: new structure segend annotations
pszgaspar Aug 30, 2026
File filter

Filter by extension

Filter by extension

Conversations
Failed to load comments.
Loading
Jump to
The table of contents is too big for display.
Diff view
Diff view
  •  
  •  
  •  
17,372 changes: 8,686 additions & 8,686 deletions drug_data/03_FinalData.csv

Large diffs are not rendered by default.

664 changes: 332 additions & 332 deletions drug_data/08_TargetPrioritazion_Data_DiseaseAssociations.csv

Large diffs are not rendered by default.

14 changes: 7 additions & 7 deletions drug_data/170829_drug_data.csv
Original file line number Diff line number Diff line change
Expand Up @@ -235,7 +235,7 @@
233,codeine,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD124,-,Analgesics,4,,-,approved,2009,,17139284|17016423|17620111|7885194
234,conivaptan,small molecule,Peptide,antagonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,519,"conivaptan, ym-087,vaprisol",hyponatremia,4,,-,approved,2005,,11752352|15659304|16843091|17919259|17202666|17592003|19695403|16522696|19057376|20054444|17428103|19663609
235,conivaptan,small molecule,Peptide,antagonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,519,"conivaptan, ym-087,vaprisol",hyponatremia,4,,-,approved,2005,,11752352|17919259|17202666|17592003|19695403|16522696|19057376|20054444|17428103|19663609
236,corticorelin ovine triflutate,small molecule,Aminergic ,agonist,,primary,CRHR1,crfr1_human,P34998,Class A (Rhodopsin),GPCR;Secretin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_409,corticorelin ovine triflutate,Diagnostic,4,,-,approved,1996,endogenous ligand,20809121
236,corticorelin ovine triflutate,small molecule,Aminergic ,agonist,,primary,CRHR1,crhr1_human,P34998,Class A (Rhodopsin),GPCR;Secretin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_409,corticorelin ovine triflutate,Diagnostic,4,,-,approved,1996,endogenous ligand,20809121
237,cosyntropin,peptide,Peptide,agonist,,primary,MC2R,acthr_human,Q01718,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,established,NRDD128,-,Diagnostic,4,,-,approved,1970,,15710205|2156274|20562554|11752352
238,cromolyn sodium,small molecule,Orphan ,agonist,chromoglycate ,primary,GPR35,gpr35_human,Q9HC97,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,established,MMA_jun2017_010,cromolyn sodium,anti-allergenic,4,-,-,approved,2000,,20559017
239,cyclizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD130,-,Antiemetics,4,,-,approved,1982,,11752352|1983158
Expand Down Expand Up @@ -1763,7 +1763,7 @@
1761,CNTX-0290,small molecule,Peptide,agonist,,primary,SSTR4,ssr4_human,P31391,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,MMAaug2017_046,CNTX-0290,Analgesics,1,2017,completed,in trial,-,,
1762,CNTX-6970,small molecule,Protein,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,MMAaug2017_044,CNTX-6970,Analgesics,1,2017,completed,in trial,-,,
1763,corifollitropin alfa,protein,Protein,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,526,"corifollitropin alfa,elonva",Fertility,3,2015,recruiting,in trial,-,,
1764,corticotropin-releasing factor,peptide,Peptide,agonist,,primary,CRHR1,crfr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,528,"corticotropin-releasing factor,xerecept",peritumoral brain edema,3,2005,discontinued,in trial,-,,
1764,corticotropin-releasing factor,peptide,Peptide,agonist,,primary,CRHR1,crhr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,528,"corticotropin-releasing factor,xerecept",peritumoral brain edema,3,2005,discontinued,in trial,-,,
1765,cpb-307,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,MMAmar2016_0127,cpb-307,autoimmune diseases,1,2014,completed,in trial,-,,
1766,cr665,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,539,"cr665, JNJ 38488502",Analgesics,2,2004,discontinued,in trial,-,,
1767,cr845,small molecule,Peptide,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,540,cr845,Analgesics,3,2015,recruiting,in trial,-,,
Expand Down Expand Up @@ -1812,7 +1812,7 @@
1810,eltoprazine,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0087,eltoprazine,dyskinesias,2,2015,ongoing,in trial,-,,
1811,elubrixin,small molecule,Protein,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_300,elubrixin,ulcerative colitis,2,2007,discontinued,in trial,-,,
1812,ema401,small molecule,Peptide,antagonist,,primary,AGTR2,agtr2_human,P50052,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,not established,MMAmay2016_0377,ema401,peripheral neuropathic pain; post herpetic neuralgia,2,2017,not open yet,in trial,-,,
1813,emicerfont,small molecule,Peptide,antagonist,,primary,CRHR1,crfr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,ASH_Sep2016_330,emicerfont,irritable bowel syndrome,2,2007,discontinued,in trial,-,,
1813,emicerfont,small molecule,Peptide,antagonist,,primary,CRHR1,crhr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,ASH_Sep2016_330,emicerfont,irritable bowel syndrome,2,2007,discontinued,in trial,-,,
1814,ep-100,peptide,Peptide,not available,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,715,ep-100,Antineoplastic,2,2011,completed,in trial,-,Seems like still investigating as of 2014 article,
1815,ep-100,peptide,Peptide,not available,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,715,ep-100,Antineoplastic,2,2011,completed,in trial,-,Seems like still investigating as of 2014 article,
1816,epelsiban,small molecule,Peptide,antagonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,ASH_Sep2016_291,epelsiban,premature ejaculation,2,2016,withdrawn,in trial,-,"Had no activity since 2009, then shows 2016 a phase 2 trial, but withdrawn due to change in portfolio prioritization",
Expand Down Expand Up @@ -2142,7 +2142,7 @@
2140,pd-6735,small molecule,Melatonin ,agonist,tik-301,primary,MTNR1B,mtr1b_human,P49286,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1575,"pd-6735, ly-156735, tik-301",Hypnotics and Sedatives,2,2004,completed,in trial,-,May still be researched,
2141,pdc31,peptide,Lipid ,antagonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmay2016_0526,pdc31,pre-term labor; dysmenorrhea,1,2010,completed,in trial,-,,
2142,peptide yy,peptide,Peptide,agonist,,primary,NPY2R,npy2r_human,P49146,Class A (Rhodopsin),GPCR;Rhodopsin,Neuropeptide Y receptors,not established,699,eligen pyy-3-36 + glp-1,Appetite suppressant,1,2009,completed,in trial,-,endogenous ligand,
2143,pexacerfont,small molecule,Peptide,antagonist,,primary,CRHR1,crfr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,ASH_Sep2016_331,pexacerfont,anxiety,3,2008,discontinued,in trial,-,,
2143,pexacerfont,small molecule,Peptide,antagonist,,primary,CRHR1,crhr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,ASH_Sep2016_331,pexacerfont,anxiety,3,2008,discontinued,in trial,-,,
2144,pf-00610355,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1591,pf-00610355,Bronchodilator,2,2009,discontinued,in trial,-,,
2145,pf-03654746,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_245,pf-03654746,allergic rhinitis,2,2011,discontinued,in trial,-,,
2146,pf-03654764,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_244,pf-03654764,allergic rhinitis,2,2009,discontinued,in trial,-,,
Expand Down Expand Up @@ -2314,7 +2314,7 @@
2312,ulocuplumab,antibody,Protein,antagonist,bms 936564,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,369,"bms 936564, mdx-1338",Antineoplastic,3,2017,ongoing,in trial,-,"discontinued for sole intervention, now in combination trials",
2313,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmar2016_0193,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",chronic obstructive pulmonary disease (COPD),3,2016,ongoing,in trial,-,,23435542
2314,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmar2016_0194,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",chronic obstructive pulmonary disease (COPD),3,2016,ongoing,in trial,-,,23435542
2315,urocortin 2,peptide,Peptide,agonist,,primary,CRHR2,crfr2_human,Q13324,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,2105,"urocortin 2, 358-086-15",congestive heart failure,2,2012,discontinued,in trial,-,,
2315,urocortin 2,peptide,Peptide,agonist,,primary,CRHR2,crhr2_human,Q13324,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,2105,"urocortin 2, 358-086-15",congestive heart failure,2,2012,discontinued,in trial,-,,
2316,v24343,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,2112,v24343,Anti-obesity,1,2008,discontinued,in trial,-,,
2317,v81444,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAmay2016_0766,"v81444, CPI 444",Antiparkinson,2,2014,completed,in trial,-,,
2318,va106483,small molecule,Peptide,agonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2115,"va106483, Fedovapagon",BPH-related urinary symptoms,3,2015,recruiting,in trial,-,,
Expand All @@ -2328,7 +2328,7 @@
2326,velneperit,small molecule,Peptide,antagonist,,primary,NPY5R,npy5r_human,Q15761,Class A (Rhodopsin),GPCR;Rhodopsin,Neuropeptide Y receptors,not established,2144,"velneperit, s-2367",Anti-obesity,2,2010,discontinued,in trial,-,,
2327,velusetrag,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2145,"velusetrag, td-5108",motilitant,2,2014,ongoing,in trial,-,,
2328,vercirnon,small molecule,Protein,antagonist,,primary,CCR9,ccr9_human,P51686,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_294,vercirnon,crohn's disease,3,2011,discontinued,in trial,-,,
2329,verucerfont,small molecule,Peptide,antagonist,nbi-77860,primary,CRHR1,crfr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,MMA2016_0047,"verucerfont, nbi-77860, 561679",Congenital Adrenal Hyperplasia,2,2013,completed,in trial,-,,
2329,verucerfont,small molecule,Peptide,antagonist,nbi-77860,primary,CRHR1,crhr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,MMA2016_0047,"verucerfont, nbi-77860, 561679",Congenital Adrenal Hyperplasia,2,2013,completed,in trial,-,,
2330,vestipitant,small molecule,Peptide,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,2148,"vestipitant, gw 597599",tinnitus; hypnotic,2,2012,discontinued,in trial,-,,
2331,vibegron,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAaug2017_002,"MK-4618, RVT-901",Urinary incontinence,2,2017,completed,in trial,,,
2332,vicriviroc,small molecule,Protein,antagonist,,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,2157,vicriviroc,antiviral ; HIV,3,2007,discontinued,in trial,-,,
Expand Down Expand Up @@ -2397,7 +2397,7 @@
2395,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,not open yet,in trial,-,,
2396,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,not open yet,in trial,-,,
2397,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,not open yet,in trial,-,,
2398,corticotropin-releasing factor,peptide,Peptide,agonist,,secondary,CRHR2,crfr2_human,Q13324,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,528,"corticotropin-releasing factor,xerecept",peritumoral brain edema,3,2005,discontinued,in trial,-,,
2398,corticotropin-releasing factor,peptide,Peptide,agonist,,secondary,CRHR2,crhr2_human,Q13324,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,528,"corticotropin-releasing factor,xerecept",peritumoral brain edema,3,2005,discontinued,in trial,-,,
2399,darusentan,small molecule,Peptide,antagonist,,secondary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,ASH_Sep2016_253,darusentan,Antihypertensive,3,2006,discontinued,in trial,-,,
2400,davalintide,protein,Peptide,agonist,,secondary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,ASH_Sep2016_328,davalintide,Anti-obesity,2,2008,discontinued,in trial,-,,
2401,dexpramipexole,small molecule,Aminergic ,agonist,,secondary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,627,"dexpramipexole, kns-760704",amyotrophic lateral sclerosis (ALS),3,2012,terminated,in trial,-,Did not meet its primary efficacy endpoint,
Expand Down
2 changes: 2 additions & 0 deletions g_protein_data/g_protein_chimeras.fasta
Original file line number Diff line number Diff line change
Expand Up @@ -156,6 +156,8 @@ TLSAEDKAAVERSKMIEKQLQKDKQVYRATHRLLLLGADNSGKSTIVKQMRIRVKTSGIFETKFQVDKVNFHMFDVGAQR
CTLSAEDKAAVERSKMIDRNLREDGEKARREVKLLLLGAGESGKSTIVKQMKIIHTTGIVETHFTFKSIHFKMFDVGGQRSERKKWIHCFEGVTAIIFCVALSDYDLVLMNRMHESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKIKKSPLTICYPEYAGSNTYEEAAAYIQCQFEDLNKRKDTKEIYTHFTCATDTKNVQFVFCAVKDTILQNNLKECNLV
>gnai1_human|9EPQ
CTLSAEDKAAVERSKMIDRNLREDGEKARREVKLLLLGAGESGKSTIVKQMKIIHETTGIVETHFTFKSIHFKMFDVGGQRSERKKWIHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMHESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKIKKSPLTICYPEYAGSNTYEEAAAYIQCQFEDLNKRKDTKEIYTHFTCATDTKNVQFVFCAVKDTILQNNLKECNLV
>gnai1_human|9LL7
LSAEDKAAVERSKMIDRNLREDGEKAAREVKLLLLGAGESGKNTIVKQMKIIHTGIVETHFTFKDLHFKMFDVGAQRSERKKWIHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMHASMKLFDSICNNKWFTDTSIILFLNKKDLFEEKIKKSPLTICYPEYAGSNTYEEAAAYIQCQFEDLNKRKDTKEIYTHFTCSTDTKNVQFVFDAVTDVIIKNNLKDCGLF
>gnat1_bovin
MGAGASAEEKHSRELEKKLKEDAEKDARTVKLLLLGAGESGKSTIVKQMKIIHQDGYSLEECLEFIAIIYGNTLQSILAIVRAMTTLNIQYGDSARQDDARKLMHMADTIEEGTMPKEMSDIIQRLWKDSGIQACFDRASEYQLNDSAGYYLSDLERLVTPGYVPTEQDVLRSRVKTTGIIETQFSFKDLNFRMFDVGGQRSERKKWIHCFEGVTCIIFIAALSAYDMVLVEDDEVNRMHESLHLFNSICNHRYFATTSIVLFLNKKDVFSEKIKKAHLSICFPDYNGPNTYEDAGNYIKVQFLELNMRRDVKEIYSHMTCATDTQNVKFVFDAVTDIIIKENLKDCGLF
>gnat1_bovin|4X1H
Expand Down
2 changes: 2 additions & 0 deletions g_protein_data/g_protein_chimeras_gapped.fasta
Original file line number Diff line number Diff line change
Expand Up @@ -158,6 +158,8 @@ MGCTLSAEDKAAVERSKMIDRNLREDGEKAAREVKLLLLGAGESGKSTIVKQMKIIHEAGYSEEECKQYKAVVYSNTIQS
--CTLSAEDKAAVERSKMIDRNLREDGEKARREVKLLLLGAGESGKSTIVKQMKIIH---------------------------------------------------------------------------------------------------------------------------TTGIVETHFTFKSIHFKMFDVGGQRSERKKWIHCFEGVTAIIFCVALSDYDLVL-----MNRMHESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKIK--KSPLTICYPEYAGS-------------NTYEEAAAYIQCQFEDLNKRKDTKE--IYTHFTCATDTKNVQFVFCAVKDTILQNNLKECNLV
>gnai1_human|9EPQ
--CTLSAEDKAAVERSKMIDRNLREDGEKARREVKLLLLGAGESGKSTIVKQMKIIHE--------------------------------------------------------------------------------------------------------------------------TTGIVETHFTFKSIHFKMFDVGGQRSERKKWIHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMHESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKIK--KSPLTICYPEYAGS-------------NTYEEAAAYIQCQFEDLNKRKDTKE--IYTHFTCATDTKNVQFVFCAVKDTILQNNLKECNLV
>gnai1_human|9LL7
----LSAEDKAAVERSKMIDRNLREDGEKAAREVKLLLLGAGESGKNTIVKQMKIIH----------------------------------------------------------------------------------------------------------------------------TGIVETHFTFKDLHFKMFDVGAQRSERKKWIHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMHASMKLFDSICNNKWFTDTSIILFLNKKDLFEEKIK--KSPLTICYPEYAGS-------------NTYEEAAAYIQCQFEDLNKRKDTKE--IYTHFTCSTDTKNVQFVFDAVTDVIIKNNLKDCGLF
>gnat1_bovin
----MGAGASAEEKHSRELEKKLKEDAEKDARTVKLLLLGAGESGKSTIVKQMKIIHQDGYSLEECLEFIAIIYGNTLQSILAIVRAMTTLNIQYGDSARQDDARKLMHMADTIEEGTMPKEMSDIIQRLWKDSGIQACFDRASEYQLNDSAGYYLSDLERLVTPGYVPTEQDVLRSRVKTTGIIETQFSFKDLNFRMFDVGGQRSERKKWIHCFEGVTCIIFIAALSAYDMVLVEDDEVNRMHESLHLFNSICNHRYFATTSIVLFLNKKDVFSEKIKKAHLSICFPDYNGPNTYEDAGNYIKVQFLELNMRRDVKEIYSHMTCATDTQNVKFVFDAVTDIIIKENLKDCGLF
>gnat1_bovin|4X1H
Expand Down
Loading